acalabrutinib
Acalabrutinib is a drug used to treat Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Small Lymphocytic Lymphoma, and other conditions. Acalabrutinib is being actively studied in 66 studies and prior, has been studied in 14.
Top Sponsors | Top Sites | Top Investigators |
---|---|---|
Acerta Pharma BV | Research Site | Austin I Kim |
AstraZeneca | M D Anderson Cancer Center | Carsten Utoft Niemann |
M.D. Anderson Cancer Center | Beth Israel Deaconess Medical Center | Craig Moskowitz |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Recruiting
- Central Nervous System Lymphoma
- Acalabrutinib
- Isavuconazole
- Chapel Hill, North Carolina
- +1 more
2022-03-24
Mar 24, 2022W
Withdrawn
- Chronic Lymphocytic Leukemia
- CLL/SLL
- Acalabrutinib
- New York, New YorkWeill Cornell Medicine
2022-03-25
Mar 25, 2022D
Recruiting
- Post-transplant Lymphoproliferative Disorder
- Rituximab
- +2 more
- Cleveland, OhioCleveland Clinic, Case Comprehensive Cancer Center
2022-02-02
Feb 2, 2022U
Not yet recruiting
- Mantle Cell Lymphoma
- Acalabrutinib
- Rituximab
- (no location specified)
2021-08-04
Aug 4, 2021D
Recruiting
- Central Nervous System Lymphoma
- +2 more
- Acalabrutinib
- Boston, Massachusetts
- +1 more
2022-01-05
Jan 5, 2022U
Recruiting
- Mantle Cell Lymphoma
- Acalabrutinib
- R-CHOP chemotherapy
- Vancouver, British Columbia, Canada
- +3 more
2022-03-17
Mar 17, 2022W
Active, not recruiting
- Mantle Cell Lymphoma
- Bendamustine
- +7 more
- Saint Louis, MissouriWashington University School of Medicine
2022-02-02
Feb 2, 2022U
Active, not recruiting
- Chronic Lymphocytic Leukemia (CLL)
- Small Lymphocytic Lymphoma (SLL)
- Acalabrutinib
- Rituximab
- Rochester, New YorkUniversity of Rochester
2022-02-07
Feb 7, 2022W
Recruiting
- Primary Central Nervous System Lymphoma
- Secondary Central Nervous System Lymphoma
- Durvalumab
- Acalabrutinib
- Saint Louis, MissouriWashington University School of Medicine
2022-03-14
Mar 14, 2022F
Recruiting
- Recurrent Moderate-Severe Chronic Graft Versus Host Disease
- Hematopoietic and Lymphoid Cell Neoplasm
- Acalabrutinib
- Questionnaire Administration
- Tampa, Florida
- +3 more
2021-12-22
Dec 22, 2021C
Recruiting
- Autoimmune Hemolytic Anemia
- +3 more
- Acalabrutinib
- Duarte, CaliforniaCity of Hope Medical Center
2022-03-09
Mar 9, 2022A
Completed
- Healthy Volunteers
- Acalabrutinib
- +2 more
- Tempe, ArizonaCelerion
2021-11-17
Nov 17, 2021A
S
Recruiting
- Diffuse Large B Cell Lymphoma
- Carboplatin
- +8 more
- Seattle, WashingtonSwedish Cancer Institute
2021-03-01
Mar 1, 2021M
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Acalabrutinib
- Obinutuzumab
- Houston, TexasM D Anderson Cancer Center
2021-11-18
Nov 18, 2021J
Not yet recruiting
- Diffuse Large B-Cell Lymphoma
- +3 more
- Acalabrutinib
- Los Angeles, California
- +2 more
2022-03-17
Mar 17, 2022F
Not yet recruiting
- Recurrent Chronic Lymphocytic Leukemia
- +3 more
- Acalabrutinib
- Venetoclax
- Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
2022-03-31
Mar 31, 2022N
Recruiting
- Non-Hodgkin's Lymphoma
- +3 more
- DA-EPOCH
- +3 more
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022A
Completed
- Hepatic Impairment
- +2 more
- acalabrutinib
- Miami, Florida
- +2 more
2021-08-16
Aug 16, 2021J
Recruiting
- Food Allergy
- Food Allergy Peanut
- Acalabrutinib
- Baltimore, MarylandJohns Hopkins Bayview Medical Center
2021-12-30
Dec 30, 2021U
Recruiting
- B-Cell Non-Hodgkin Lymphoma
- +7 more
- Acalabrutinib
- Axicabtagene Ciloleucel
- Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
2022-03-16
Mar 16, 2022N
Recruiting
- Recurrent Follicular Lymphoma
- +8 more
- Acalabrutinib
- Duvelisib
- Columbus, OhioOhio State University Comprehensive Cancer Center
2021-12-16
Dec 16, 2021J
M
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Acalabrutinib
- +4 more
- Scottsdale, Arizona
- +2 more
2021-08-19
Aug 19, 2021S
Recruiting
- Waldenstrom Macroglobulinemia
- Acalabrutinib
- +2 more
- Vancouver, British Columbia, Canada
- +3 more
2021-07-23
Jul 23, 2021